| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $174.7M | -5.3% |
| Cost of Revenue | $8.8M | -2.1% |
| R&D Expense | $28.1M | -22.8% |
| SG&A Expense | $76.9M | +8.9% |
| Operating Income | $766K | -94.8% |
| Pre-tax Income | $3.4M | -72.6% |
| Income Tax | $93K | +102.2% |
| Net Income | $2.0M | -74.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $62.4M | +20.1% |
| Accounts Receivable | $14.6M | +45.3% |
| Current Assets | $84.9M | +22.2% |
| Total Assets | $190.7M | +4.8% |
| Current Liabilities | $36.2M | +19.1% |
| Total Liabilities | $58.9M | -4.7% |
| Stockholders' Equity | $57.2M | +58.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $26.2M | -28.6% |
| Investing Cash Flow | -$12.7M | -9.0% |
| Financing Cash Flow | -$3.1M | +58.7% |